Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Manon L. M. Prins"'
Autor:
Manon L. M. Prins, Geert V. T. Roozen, Cilia. R. Pothast, Wesley Huisman, Rob van Binnendijk, Gerco den Hartog, Vincent P. Kuiper, Corine Prins, Jacqueline J. Janse, Olivia. A. C. Lamers, Jan Pieter R. Koopman, Annelieke C. Kruithof, Ingrid M. C. Kamerling, Romy C. Dijkland, Alicia. C. de Kroon, Shohreh Azimi, Mariet C. W. Feltkamp, Marjan Kuijer, Simon P. Jochems, Mirjam H. M. Heemskerk, Frits R. Rosendaal, Meta Roestenberg, Leo G. Visser, Anna H. E. Roukens
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-10 (2024)
Abstract Fractional dosing can be a cost-effective vaccination strategy to accelerate individual and herd immunity in a pandemic. We assessed the immunogenicity and safety of primary intradermal (ID) vaccination, with a 1/5th dose compared with the s
Externí odkaz:
https://doaj.org/article/8c7cdcae1f5e4775b3bf74058e2d2a84
Autor:
Manon L. M. Prins, Johan L. van der Plas, Maurits F. J. M. Vissers, Cécile L. Berends, Gaby Tresch, Marianne Soergel, Elena Fernández, Nikita van den Berge, Daniël Duijsings, Christof Zitt, Vaia Stavropoulou, Maya Zimmermann, Roxana F. Drake, Jacobus Burggraaf, Geert H. Groeneveld, Ingrid M. C. Kamerling
Publikováno v:
British Journal of Clinical Pharmacology. 89:1105-1114
To assess viral clearance, pharmacokinetics, tolerability and symptom evolution following ensovibep administration in symptomatic COVID-19 outpatients.In this open-label, first-in-patient study a single dose of either 225 mg (n = 6) or 600 mg (n = 6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4486ba530537593fd09db4384b64cdaa
https://doi.org/10.1111/bcp.15560
https://doi.org/10.1111/bcp.15560